Search research articles
Contact Us
Filters
Showing results (61-70 of 102) with videos related to
Page
of 11
Sort By:
European Review for Medical and Pharmacological Sciences
|
July 21, 2021
Efficacy and efficiency of Green-Light XPS 180-watt laser system for benign prostatic enlargement in patients treated with 5α-reductase inhibitors
J Ghahhari, C De Nunzio, R Lombardo, et al.
The Journal of Pharmacy and Pharmacology
|
January 24, 2002
Topical anti-inflammatory activity of Thymus willdenowii
H Ismaili, S Tortora, S Sosa, et al.
Journal of Ethnopharmacology
|
July 1, 1997
Anti-oedematous activities of the main triterpendiol esters of marigold (Calendula officinalis L.)
K Zitterl-Eglseer, S Sosa, J Jurenitsch, et al.
Current Drug Discovery Technologies
|
May 23, 2006
Anti-inflammatory and anti-oxidant activity of a new class of phenyl-pyrazolone derivatives
C Cusan, G Altinier, S Sosa, et al.
The Journal of Urology
|
October 1, 1996
Pressure-flow study analyses in patients treated with high energy thermotherapy
J J de la Rosette, M J de Wildt, K Höfner, et al.
The Journal of Urology
|
July 1, 1996
High energy thermotherapy in the treatment of benign prostatic hyperplasia: results of the European Benign Prostatic Hyperplasia Study Group
J J de la Rosette, M J de Wildt, K Höfner, et al.
Toxicology Letters
|
September 22, 2009
Palytoxin toxicity after acute oral administration in mice
S Sosa, G Del Favero, M De Bortoli, et al.
Prostate Cancer and Prostatic Diseases
|
October 7, 2015
Metabolic abnormalities linked to an increased cardiovascular risk are associated with high-grade prostate cancer: a single biopsy cohort analysis
C De Nunzio, G Truscelli, A Trucchi, et al.
Annali Dell'Istituto Superiore Di Sanita
|
January 1, 1990
Local/regional recombinant interleukin 2 (rIL-2) immunotherapy of tumors. Intra-arterial continuous infusion of rIL-2 in bladder cancer patients: a phase I study
F Velotti, A Tubaro, A Stoppacciaro, et al.
Prostate Cancer and Prostatic Diseases
|
February 22, 2017
Meta-analysis of metabolic syndrome and prostate cancer
M Gacci, G I Russo, C De Nunzio, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 102) with videos related to
Sort By:
Page
of 11
European Review for Medical and Pharmacological Sciences
|
July 21, 2021
Efficacy and efficiency of Green-Light XPS 180-watt laser system for benign prostatic enlargement in patients treated with 5α-reductase inhibitors
J Ghahhari, C De Nunzio, R Lombardo, et al.
The Journal of Pharmacy and Pharmacology
|
January 24, 2002
Topical anti-inflammatory activity of Thymus willdenowii
H Ismaili, S Tortora, S Sosa, et al.
Journal of Ethnopharmacology
|
July 1, 1997
Anti-oedematous activities of the main triterpendiol esters of marigold (Calendula officinalis L.)
K Zitterl-Eglseer, S Sosa, J Jurenitsch, et al.
Current Drug Discovery Technologies
|
May 23, 2006
Anti-inflammatory and anti-oxidant activity of a new class of phenyl-pyrazolone derivatives
C Cusan, G Altinier, S Sosa, et al.
The Journal of Urology
|
October 1, 1996
Pressure-flow study analyses in patients treated with high energy thermotherapy
J J de la Rosette, M J de Wildt, K Höfner, et al.
The Journal of Urology
|
July 1, 1996
High energy thermotherapy in the treatment of benign prostatic hyperplasia: results of the European Benign Prostatic Hyperplasia Study Group
J J de la Rosette, M J de Wildt, K Höfner, et al.
Toxicology Letters
|
September 22, 2009
Palytoxin toxicity after acute oral administration in mice
S Sosa, G Del Favero, M De Bortoli, et al.
Prostate Cancer and Prostatic Diseases
|
October 7, 2015
Metabolic abnormalities linked to an increased cardiovascular risk are associated with high-grade prostate cancer: a single biopsy cohort analysis
C De Nunzio, G Truscelli, A Trucchi, et al.
Annali Dell'Istituto Superiore Di Sanita
|
January 1, 1990
Local/regional recombinant interleukin 2 (rIL-2) immunotherapy of tumors. Intra-arterial continuous infusion of rIL-2 in bladder cancer patients: a phase I study
F Velotti, A Tubaro, A Stoppacciaro, et al.
Prostate Cancer and Prostatic Diseases
|
February 22, 2017
Meta-analysis of metabolic syndrome and prostate cancer
M Gacci, G I Russo, C De Nunzio, et al.
Page
of 11